Author

Shoko Wakabayashi

Harvard University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:chromatin & epigenetic regulation· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:non-human primate· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Philana Ling LiniD· 2 shared Sarah M. FortuneiD· 2 shared Andrew J VickersiD· 1 shared Benjamin Braunecker· 1 shared Byron Roman· 1 shared Collin R. DiedrichiD· 1 shared Dirk SchnappingeriD· 1 shared Douaa MugahidiD· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Philana Ling LinORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologymSystemsPeer-reviewedJul 27, 2026

Population-level genome sequencing reveals distinct Mycobacterium tuberculosis intrahost mutational trajectories in simian immunodeficiency virus co-infected and antiretroviral treated non-human primates

Michael C. Chao, Michael R. Chase, Shoko Wakabayashi…·Sarah M. Fortune

This study uses whole genome sequencing of Mycobacterium tuberculosis in non-human primates to identify distinct mutational trajectories in SIV-co-infected and ART-treated animals, revealing differential immune pressures and mutation patterns.

1 citationtop 5%

non-human primatewhole-genome sequencing

𝕏 PostBluesky

MicrobiologybioRxivPreprintNov 19, 2023

Development of an Engineered Mycobacterium tuberculosis Strain for a Safe and Effective Tuberculosis Human Challenge Model

Xin Wang, Hongwei Su, Joshua B. Wallach…·Dirk Schnappinger

This paper develops an engineered Mycobacterium tuberculosis strain with kill switches for a safe TB human challenge model, showing rapid clearance and low escape rates.

DOI 10.1101/2023.11.19.567569

genetic perturbation / CRISPR

𝕏 PostBluesky